Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,270 | 10-14 weeks | |
50 mg | $2,980 | 10-14 weeks | |
100 mg | $4,000 | 10-14 weeks |
Description | c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity. |
In vitro | c-Met-IN-2 (Compound 14) also shows weak activity on other kinases, with IC50s of 731 nM (RON), 1075 nM (AxI), 18364 nM (VEGFR2), 2357 nM (PDGFRa), 5396 nM (c-Kit), 17056 nM (c-Src). |
In vivo | In mice bearing H1993 tumors, c-Met-IN-2 (0.1, 1, 10 mg/kg, p.o., once daily) significantly reduces the volume of tumors. c-Met-IN-2 has a similar effect in SNU-5 xenograft model via oral administration at 0.3, 1 and 3 mg/kg. |
Molecular Weight | 484.49 |
Formula | C24H21FN10O |
Cas No. | 1635406-73-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.